6986 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and new drug development. Its production line includes various core technologies required by the cell therapy industry to provide CMO (contracted production services) and CDMO (commissioned development and manufacturing services) and testing services. The company was founded by Cheng Han Wen on June 12, 2019 and is headquartered in Taoyuan, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6986 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company